We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
+26.3%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$12.9B
AUM Growth
+$151M
(+1.2%)
Cap. Flow
-$2.53B
Cap. Flow
% of AUM
-19.61%
Top 10 Holdings %
Top 10 Hldgs %
34.42%
Holding
917
New
232
Increased
199
Reduced
245
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$344M |
| 2 |
Vale
VALE
|
+$168M |
| 3 |
AT&T
T
|
+$137M |
| 4 |
S&P Global
SPGI
|
+$131M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$416M |
| 2 |
Microsoft
MSFT
|
+$406M |
| 3 |
Merck
MRK
|
+$180M |
| 4 |
Starbucks
SBUX
|
+$165M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.33% |
| 2 | Technology | 11.78% |
| 3 | Healthcare | 9.81% |
| 4 | Financials | 9.42% |
| 5 | Industrials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Quince Therapeutics
QNCX
$17.5M
| $564K | ﹤0.01% |
61
-22
| -27% | -$202K |
|
602
Cintas
CTAS
$82.4B
| $560K | ﹤0.01% |
8,412
-646,264
| -99% | -$37.4M |
|
603
Cadence Design Systems
CDNS
$90B
| $555K | ﹤0.01% |
5,781
-66,301
| -92% | -$5.55M |
|
604
Nutrien
NTR
$32.7B
| $553K | ﹤0.01% |
17,267
+9,368
| +119% | +$326K |
|
605
Clorox
CLX
$11.6B
| $552K | ﹤0.01% |
2,518
-395,751
| -99% | -$79.1M |
|
606
Shake Shack
SHAK
$2.3B
| $547K | ﹤0.01% |
10,330
| – | – |
|
|
IBTX
607
DELISTED
Independent Bank Group, Inc.
IBTX
| $543K | ﹤0.01% |
+13,396
| New | +$434K |
|
608
TC Energy
TRP
$73.5B
| $542K | ﹤0.01% |
+12,728
| New | +$571K |
|
609
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
| $539K | ﹤0.01% |
11,455
-6,427
| -36% | -$292K |
|
610
Bank of Montreal
BMO
$125B
| $537K | ﹤0.01% |
10,111
-20,652
| -67% | -$1.05M |
|
611
Universal Health Services
UHS
$9.43B
| $524K | ﹤0.01% |
5,637
-23,294
| -81% | -$2.33M |
|
612
Zillow
ZG
$7.02B
| $517K | ﹤0.01% |
+9,000
| New | +$443K |
|
613
Pultegroup
PHM
$24.5B
| $516K | ﹤0.01% |
15,176
-72,764
| -83% | -$2.18M |
|
614
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
| $511K | ﹤0.01% |
14,764
| – | – |
|
615
JD.com
JD
$40.8B
| $503K | ﹤0.01% |
8,437
-69,388
| -89% | -$3.51M |
|
616
KeyCorp
KEY
$24.3B
| $502K | ﹤0.01% |
+41,211
| New | +$479K |
|
617
Q2 Holdings
QTWO
$3.42B
| $498K | ﹤0.01% |
+5,800
| New | +$446K |
|
618
Compañía de Minas Buenaventura
BVN
$7.85B
| $496K | ﹤0.01% |
54,293
+1
| +0% | +$8 |
|
619
Healthpeak Properties
DOC
$15.4B
| $492K | ﹤0.01% |
17,858
-14,035
| -44% | -$358K |
|
620
Schneider National
SNDR
$6.59B
| $488K | ﹤0.01% |
+19,800
| New | +$436K |
|
|
B
621
Barrick Mining
B
$62.2B
| $485K | ﹤0.01% |
18,007
-11,954
| -40% | -$299K |
|
622
Ionis Pharmaceuticals
IONS
$9.35B
| $484K | ﹤0.01% |
+8,210
| New | +$457K |
|
623
GSK
GSK
$103B
| $481K | ﹤0.01% |
+9,432
| New | +$484K |
|
624
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $468K | ﹤0.01% |
4,285
-282
| -6% | -$29.2K |
|
625
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
| $467K | ﹤0.01% |
18,045
| – | – |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q2 2020 Portfolio in Review
As of Q2 2020, Natixis held 917 positions worth $12.9B, up 1.2% from $12.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Natixis withdrew a net $2.53B in Q2 2020, closing 202 positions and reducing 245 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $155M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Natixis opened a new position in S&P Global worth $144M.
- Natixis's largest Q2 2020 buy was S&P Global: 436,534 shares worth $144M.
- Natixis added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $344M increase.
- Natixis's biggest Q2 2020 reduction was Apple, cutting an estimated $416M.
- Natixis fully exited State Street SPDR S&P Biotech ETF in Q2 2020, selling an estimated $155M.
- Natixis's ten largest holdings make up 34% of its $12.9B portfolio in Q2 2020.
- Natixis opened 232 new positions and closed 202 in Q2 2020.
- Natixis's portfolio value rose 1.2% quarter-over-quarter to $12.9B.
Based on Natixis's 13F filing for Q2 2020, filed 13 Aug 2020.